285 related articles for article (PubMed ID: 11324219)
1. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
2. [Exposure or cancer predisposition? Cytogenetic examination of head and neck squamous cancer patients].
Székely G; Remenár E; Kásler M; Gundy S
Magy Onkol; 2001; 45(2):152-157. PubMed ID: 12050710
[TBL] [Abstract][Full Text] [Related]
3. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
4. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
5. Mutagen sensitivity of patients with cancer at different sites of the head and neck.
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2005 Sep; 20(5):381-5. PubMed ID: 16105906
[TBL] [Abstract][Full Text] [Related]
6. [Problems occurring in the application of cytogenetic biomarkers for alcoholics with and without malignant diseases].
Gundy S; Székely G; Farkas G; Pulay A; Remenár E
Magy Onkol; 2008 Jun; 52(2):153-61. PubMed ID: 18640891
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
Jin C; Jin Y; Wennerberg J; Rosenquist B; Mertens F
Mutat Res; 2008 Mar; 652(1):30-7. PubMed ID: 18243046
[TBL] [Abstract][Full Text] [Related]
9. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
10. Mutagen sensitivity: a biological marker of cancer susceptibility.
Hsu TC; Spitz MR; Schantz SP
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):83-9. PubMed ID: 1726967
[TBL] [Abstract][Full Text] [Related]
11. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
12. Does the bleomycin sensitivity assay express cancer phenotype?
Székely G; Remenár E; Kásler M; Gundy S
Mutagenesis; 2003 Jan; 18(1):59-63. PubMed ID: 12473736
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
14. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
[TBL] [Abstract][Full Text] [Related]
15. Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.
Albrecht T; Deng CZ; Abdel-Rahman SZ; Fons M; Cinciripini P; El-Zein RA
Environ Mol Mutagen; 2004; 43(3):169-78. PubMed ID: 15065204
[TBL] [Abstract][Full Text] [Related]
16. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-induced chromosome damage in lymphocytes indicates inefficient DNA repair capacity in breast cancer families.
Roy SK; Trivedi AH; Bakshi SR; Patel SJ; Shukla PH; Bhatavdekar JM; Patel DD; Shah PM
J Exp Clin Cancer Res; 2000 Jun; 19(2):169-73. PubMed ID: 10965814
[TBL] [Abstract][Full Text] [Related]
18. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.
Schantz SP; Huang Q; Shah K; Murty VV; Hsu TC; Yu G; Andersen PE; Huvos AG; Chaganti RS
Carcinogenesis; 2000 Jun; 21(6):1239-46. PubMed ID: 10837016
[TBL] [Abstract][Full Text] [Related]
19. Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer.
Ankathil R; Jyothish B; Madhavan J; Nair MK
J Exp Clin Cancer Res; 1999 Mar; 18(1):33-7. PubMed ID: 10374674
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of bleomycin-exposed lymphoblastoid cells for identifying cancer susceptibility genes.
Cloos J; de Boer WP; Snel MH; van den Ijssel P; Ylstra B; Leemans CR; Brakenhoff RH; Braakhuis BJ
Mol Cancer Res; 2006 Feb; 4(2):71-7. PubMed ID: 16513838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]